vs
ARK RESTAURANTS CORP（ARKR）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是ARK RESTAURANTS CORP的1.9倍（$75.5M vs $40.7M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -9.4%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-1.8M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -1.8%）
ARK餐饮集团在美国多州运营数十家不同定位的餐饮门店，覆盖休闲正餐、快休闲餐饮及高端精致料理赛道，提供美式家常餐、烧烤、海鲜及意式美食，服务当地社区居民及往来游客。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
ARKR vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.9倍
$40.7M
营收增速更快
PBYI
高出37.1%
-9.4%
自由现金流更多
PBYI
多$16.2M
$-1.8M
两年增速更快
PBYI
近两年复合增速
-1.8%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $40.7M | $75.5M |
| 净利润 | $896.0K | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 2.7% | 22.7% |
| 净利率 | 2.2% | — |
| 营收同比 | -9.4% | 27.7% |
| 净利润同比 | -71.7% | — |
| 每股收益（稀释后） | $0.25 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARKRPBYI
| Q4 25 | $40.7M | $75.5M | ||
| Q3 25 | $37.3M | $54.5M | ||
| Q2 25 | $43.7M | $52.4M | ||
| Q1 25 | $39.7M | $46.0M | ||
| Q4 24 | $45.0M | $59.1M | ||
| Q3 24 | $43.4M | $80.5M | ||
| Q2 24 | $50.4M | $47.1M | ||
| Q1 24 | $42.3M | $43.8M |
净利润ARKRPBYI
| Q4 25 | $896.0K | — | ||
| Q3 25 | $-1.9M | $8.8M | ||
| Q2 25 | $-3.5M | $5.9M | ||
| Q1 25 | $-9.3M | $3.0M | ||
| Q4 24 | $3.2M | — | ||
| Q3 24 | $-4.5M | $20.3M | ||
| Q2 24 | $640.0K | $-4.5M | ||
| Q1 24 | $-1.4M | $-4.8M |
毛利率ARKRPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率ARKRPBYI
| Q4 25 | 2.7% | 22.7% | ||
| Q3 25 | -4.6% | 17.6% | ||
| Q2 25 | -7.8% | 12.7% | ||
| Q1 25 | -11.6% | 8.7% | ||
| Q4 24 | 12.6% | 22.6% | ||
| Q3 24 | -12.7% | 27.4% | ||
| Q2 24 | 1.6% | -4.6% | ||
| Q1 24 | -2.8% | -5.3% |
净利率ARKRPBYI
| Q4 25 | 2.2% | — | ||
| Q3 25 | -5.1% | 16.2% | ||
| Q2 25 | -7.9% | 11.2% | ||
| Q1 25 | -23.3% | 6.5% | ||
| Q4 24 | 7.0% | — | ||
| Q3 24 | -10.3% | 25.2% | ||
| Q2 24 | 1.3% | -9.6% | ||
| Q1 24 | -3.4% | -11.0% |
每股收益（稀释后）ARKRPBYI
| Q4 25 | $0.25 | $0.26 | ||
| Q3 25 | $-0.53 | $0.17 | ||
| Q2 25 | $-0.96 | $0.12 | ||
| Q1 25 | $-2.57 | $0.06 | ||
| Q4 24 | $0.88 | $0.40 | ||
| Q3 24 | $-1.24 | $0.41 | ||
| Q2 24 | $0.18 | $-0.09 | ||
| Q1 24 | $-0.40 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $9.1M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $33.7M | $130.3M |
| 总资产 | $130.4M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资ARKRPBYI
| Q4 25 | $9.1M | $97.5M | ||
| Q3 25 | $11.3M | $94.4M | ||
| Q2 25 | $12.3M | $96.0M | ||
| Q1 25 | $11.1M | $93.2M | ||
| Q4 24 | $13.1M | $101.0M | ||
| Q3 24 | $10.3M | $96.7M | ||
| Q2 24 | $11.5M | $96.8M | ||
| Q1 24 | $10.4M | $107.2M |
总债务ARKRPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益ARKRPBYI
| Q4 25 | $33.7M | $130.3M | ||
| Q3 25 | $32.7M | $115.3M | ||
| Q2 25 | $34.7M | $104.7M | ||
| Q1 25 | $38.1M | $97.1M | ||
| Q4 24 | $47.3M | $92.1M | ||
| Q3 24 | $44.1M | $71.1M | ||
| Q2 24 | $48.9M | $48.5M | ||
| Q1 24 | $49.7M | $51.0M |
总资产ARKRPBYI
| Q4 25 | $130.4M | $216.3M | ||
| Q3 25 | $133.5M | $202.9M | ||
| Q2 25 | $136.3M | $194.9M | ||
| Q1 25 | $141.9M | $196.2M | ||
| Q4 24 | $154.6M | $213.3M | ||
| Q3 24 | $156.0M | $220.7M | ||
| Q2 24 | $166.5M | $205.0M | ||
| Q1 24 | $169.6M | $214.1M |
负债/权益比ARKRPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-550.0K | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | $14.4M |
| 自由现金流率自由现金流/营收 | -4.4% | 19.1% |
| 资本支出强度资本支出/营收 | 3.1% | 0.0% |
| 现金转化率经营现金流/净利润 | -0.61× | — |
| 过去12个月自由现金流最近4个季度 | $-1.3M | $41.7M |
8季度趋势，按日历期对齐
经营现金流ARKRPBYI
| Q4 25 | $-550.0K | $14.4M | ||
| Q3 25 | $633.0K | $9.7M | ||
| Q2 25 | $1.9M | $14.1M | ||
| Q1 25 | $612.0K | $3.6M | ||
| Q4 24 | $-1.3M | $15.6M | ||
| Q3 24 | $728.0K | $11.0M | ||
| Q2 24 | $3.2M | $1.0M | ||
| Q1 24 | $208.0K | $11.2M |
自由现金流ARKRPBYI
| Q4 25 | $-1.8M | $14.4M | ||
| Q3 25 | $-989.0K | $9.7M | ||
| Q2 25 | $1.2M | $14.1M | ||
| Q1 25 | $290.0K | $3.6M | ||
| Q4 24 | $-2.0M | $15.6M | ||
| Q3 24 | $-482.0K | $11.0M | ||
| Q2 24 | $2.5M | $1.0M | ||
| Q1 24 | $-148.0K | — |
自由现金流率ARKRPBYI
| Q4 25 | -4.4% | 19.1% | ||
| Q3 25 | -2.6% | 17.7% | ||
| Q2 25 | 2.7% | 26.8% | ||
| Q1 25 | 0.7% | 7.7% | ||
| Q4 24 | -4.4% | 26.4% | ||
| Q3 24 | -1.1% | 13.7% | ||
| Q2 24 | 5.0% | 2.1% | ||
| Q1 24 | -0.4% | — |
资本支出强度ARKRPBYI
| Q4 25 | 3.1% | 0.0% | ||
| Q3 25 | 4.3% | 0.0% | ||
| Q2 25 | 1.5% | 0.0% | ||
| Q1 25 | 0.8% | 0.1% | ||
| Q4 24 | 1.4% | 0.0% | ||
| Q3 24 | 2.8% | 0.0% | ||
| Q2 24 | 1.2% | 0.0% | ||
| Q1 24 | 0.8% | 0.0% |
现金转化率ARKRPBYI
| Q4 25 | -0.61× | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | -0.43× | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | 4.94× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
